FDA approves new type of flu vaccine

FDA approves new type of flu vaccine
Flublok easier to produce quickly and in large quantities, agency says.

(HealthDay)—The U.S. Food and Drug Administration has approved a novel type of flu vaccine, the agency announced Wednesday.

Flublok, as the vaccine is called, does not use the traditional method of the influenza virus or eggs in its production. Instead, it is made using an "insect virus (baculovirus) expression system and recombinant DNA technology," the FDA said in a news release. This will allow vaccine maker Protein Sciences Corp., of Meriden, Conn., to produce Flublok in large quantities, the agency added.

The vaccine is approved for use in those aged 18 to 49.

"This approval represents a technological advance in the manufacturing of an ," said Dr. Karen Midthun, director of the FDA's Center for Biologics Evaluation and Research. "The new technology offers the potential for faster start-up of the vaccine manufacturing process in the event of a pandemic, because it is not dependent on an egg supply or on availability of the ."

While the technology is new to production, it has been employed in the making of vaccines that prevent other infectious diseases, the agency noted.

As it does with all influenza vaccines, the FDA will assess Flublok before each . In research conducted at various sites in the United States, Flublok was about 45 percent effective against all circulating , not just the strains that matched those in the vaccine. The most commonly reported adverse reactions included pain at the site of injection, headache, fatigue and muscle aches—events also typical for conventional flu vaccines, the agency said.

The new flu vaccine could not have come at a better time, with the flu season well under way and sporadic shortages of both the traditional flu vaccine and the Tamiflu.

"We have received reports that some consumers have found spot shortages of the vaccine," FDA Commissioner Dr. Margaret Hamburg said Monday on her blog on the agency's website.

So far, more than 128 million doses of flu vaccine have been distributed, Hamburg said, but not all the doses have been administered to people yet.

She said that people who already have the flu may also be experiencing local shortages of Tamiflu.

"We do anticipate intermittent, temporary shortages of the oral suspension form of Tamiflu—the liquid version often prescribed for children—for the remainder of the flu season. However, FDA is working with the manufacturer to increase supply," she said.

Flu season typically peaks in January or February but can extend as late as May. This flu season is turning out to be more severe than last year's.

Officials at the U.S. Centers for Disease Control and Prevention said on Friday that 47 states were reporting widespread influenza activity, although flu case numbers were beginning to subside in some regions, especially in the Southeast, where the flu showed up first.

It's still not too late to get a flu shot to help protect yourself, Hamburg stressed. She noted that it takes about two weeks after vaccination for your body to develop an immune response to provide protection against the flu.

People who want to get vaccinated can visit flu.gov, click on the "Flu Vaccine Finder," enter their zip code and find a list of clinics, supermarkets, pharmacies and other flu vaccination locations in their neighborhoods.

But before you go to one of the locations, call ahead to confirm that they have the flu vaccine, Hamburg advised.

According to recommendations from the CDC, all adults and children who are at least 6 months old should receive a flu vaccination each year. The best time to get vaccinated is in the fall.

More information: The U.S. Centers for Disease Control and Prevention has more about the flu and flu vaccine.

add to favorites email to friend print save as pdf

Related Stories

FDA approves first 4-in-1 flu vaccine

Feb 29, 2012

Federal health officials have approved the first vaccine that protects against four strains of the common flu, offering one additional layer of protection against the influenza virus that affects millions each year.

FDA approves flu vaccine for coming season

Aug 14, 2012

(HealthDay) -- The formulation for the vaccine that will help protect against the flu this coming season was approved by the U.S. Food and Drug Administration on Monday.

No Excuses: Flu vaccination myths addressed

Oct 12, 2012

Flu season is here. According to the Centers for Disease Control and Prevention, each year five to 20 percent of Americans get the flu and more than 200,000 people are hospitalized due to flu-related complications. Flu season ...

Recommended for you

Novartis Japan admits concealing drug side effects

20 hours ago

The Japanese unit of Swiss pharma giant Novartis has admitted it did not report more than 2,500 cases of serious side effects in patients using its leukaemia and other cancer drugs, reportedly including some fatalities.

Most US babies get their vaccines, CDC says

Aug 28, 2014

(HealthDay)—The vast majority of American babies are getting the vaccines they need to protect them from serious illnesses, federal health officials said Thursday.

Expression of privilege in vaccine refusal

Aug 27, 2014

Not all students returning to school this month will be up to date on their vaccinations. A new study conducted by Jennifer Reich, a researcher at the University of Colorado Denver, shows that the reasons why children may ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Argiod
1 / 5 (1) Jan 17, 2013
And the countdown begins to see just how long before this new drug starts doing unexpected things and goes on the 'Bad Drug' list...
I think I'll wait a few years before considering use of it. Oh, nevermind... I'm too old for it anyways... LOL